New interleukin-23 pathway inhibitors in dermatology: ustekinumab, briakinumab, and secukinumab.

Source:http://linkedlifedata.com/resource/pubmed/id/21348542

Am J Clin Dermatol 2011 Apr 1 12 2 113-25

Download in:

View as

Triples

General Info

PMID
21348542